Plasma extracellular vesicle: a novel biomarker for neurodegenerative disease diagnosis
2024

Plasma extracellular vesicles as biomarkers for neurodegenerative diseases

Commentary Evidence: moderate

Author Information

Author(s): Zhao Xinrui, Huang Shenglin

Primary Institution: Fudan University Shanghai Cancer Center

Hypothesis

Can tau and TDP-43 proteins in plasma extracellular vesicles serve as diagnostic biomarkers for frontotemporal dementia and amyotrophic lateral sclerosis?

Conclusion

Measuring tau and TDP-43 levels in plasma extracellular vesicles could provide an effective, non-invasive diagnostic tool for frontotemporal dementia and amyotrophic lateral sclerosis.

Supporting Evidence

  • Plasma EV biomarkers demonstrate higher diagnostic accuracy and stability compared to direct plasma testing.
  • The study achieved diagnostic accuracies of over 0.9 for distinguishing between diagnostic groups.
  • 3R/4R tau ratios and TDP-43 levels were closely correlated with clinical severity indicators.

Takeaway

Scientists are studying tiny bubbles in our blood that can carry important signals about brain diseases, helping doctors diagnose conditions like dementia and ALS more easily.

Methodology

The study analyzed plasma extracellular vesicles from clinical cohorts using immunoprecipitation mass spectrometry and sandwich immunoassays to measure tau and TDP-43 levels.

Potential Biases

Potential biases may arise from the reliance on specific diagnostic groups and the need for standardized operating procedures.

Limitations

Findings need validation in larger, more diverse populations and require standardized protocols for sample collection and analysis.

Participant Demographics

Included patients with ALS, progressive supranuclear palsy, bvFTD, and healthy controls.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.20517/evcna.2024.56

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication